On June 18th, the Chinese herbal medicine index stood at 2,737 points, unchanged from yesterday and reaching a new historical high in the cycle, up 180.72% from its lowest point of 975 points on November 25, 2019. (Note: The cycle refers to June 30th, 2019 to present)

According to the price monitoring of SunSirs, in the 24th week of 2023 (6.12-6.16), there were a total of 5 products that rose or fell in the price list of traditional Chinese medicine, 2 products that fell, and 1 product that rose or fell to 0. The main commodities that have increased include: Codonopsis pilosula (13.67%), Angelica (7.24%), and Astragalus (5.88%); The main commodities that fell were Sanchi (-6.36%) and Chinese Wolfberry (-1.18%). Last week's average increase or decrease was 3.47%.

According to the monitoring of the Commodity Market Analysis System of the SunSirs, the production of first crop of Flos Lonicerae has ended, and a large number of new products have been launched. The sales situation of the source of goods in the production area has remained good. Stimulated by the high price market, pharmaceutical farmers pay attention to management, and the quality of output this year is good. The current market price of Flos Lonicerae is between 150 and 155 RMB.

The origin and market of traditional Chinese medicine are still in an overheated state, and it is difficult to predict the price increase of varieties. Perhaps today is already high priced peony bark, Codonopsis pilosula, Atractylodes macrocephala, etc., perhaps it is suddenly emerging stiff silkworms, kudzu, morning glory, etc., perhaps tomorrow is the production exceeding sales of Chonglou, Chuanxiong, Cheqianzi. There are still many varieties with rising prices in the market, while the decline in price varieties is not significant, all of which fall within the normal fluctuation range of merchant shipments.

If you have any questions, please feel free to contact SunSirs with support@sunsirs.com.